AI assistant
Sending…
CONMED Corp — Director's Dealing 2011
May 13, 2011
31971_dirs_2011-05-13_57482943-4e50-45c8-8b5d-4e8ba9640472.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2011-05-12
Reporting Person: JONAS DANIEL (VP Legal Affairs, Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-12 | Common Stock | M | 8000 | $19.93 | Acquired | 12138 | Direct |
| 2011-05-12 | Common Stock | F | 6407 | $28.98 | Disposed | 5731 | Direct |
| 2011-05-12 | Common Stock | M | 2000 | $16.46 | Acquired | 7731 | Direct |
| 2011-05-12 | Common Stock | F | 1449 | $28.98 | Disposed | 6282 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-12 | Sars (Stock Appreciation Rights) | $19.93 | M | 8000 | Disposed | 2016-05-16 | Common Stock (8000) | Direct |
| 2011-05-12 | Sars (Stock Appreciation Rights) | $16.46 | M | 2000 | Disposed | 2019-06-01 | Common Stock (2000) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7